Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

News   Oct 19, 2017 | Original story written by Nathan Collins for Stanford University

 
Scientists Develop a Synthetic Solution to Combat Dwindling Supply of Cancer and HIV Drug

Stanford scientists have developed a synthetic substitute for a drug derived from Bugula neritina, or spiral-tufted bryozoan. (Image credit: Fitzgerald Marine Reserve Docent/Creative Commons)

 
 
 

RELATED ARTICLES

Antimalarial Drugs Could Offer Clinical Benefit to Cancer Patients

News

Antimalarial drugs chloroquine and hydroxychloroquine could find another use as cancer treatments, according to a new clinical study published in ecancermedicalscience.

READ MORE

Chemists Design More Efficient Microreactor Using 3D Printing

News

Researchers developed an electrochemical microreactor using additive manufacturing technology (commonly known as 3D printing). The newly developed microreactor was tested on synthesis of isoindolinones, which are found in many natural products, pharmaceuticals, and biologically active molecules.

READ MORE

Antibiotic Resistance Genes Successfully Blocked

News

Scientists at UdeM's Department of Biochemistry and Molecular Medicine design better molecules that make it harder for plasmids to move between bacteria.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE